Flaumenhaft RC - Search Results

1

Shear-Mediated Platelet Microparticles Demonstrate Phenotypic Heterogeneity as to Morphology, Receptor Distribution, and Hemostatic Function.

Roka-Moiia Y, Ammann KR, Miller-Gutierrez S, Sheriff J, Bluestein D, Italiano JE, Flaumenhaft RC, Slepian MJ. Roka-Moiia Y, et al. Among authors: flaumenhaft rc. Int J Mol Sci. 2023 Apr 17;24(8):7386. doi: 10.3390/ijms24087386. Int J Mol Sci. 2023. PMID: 37108551 Free PMC article.

2

Discovery of 1,3-Diaminobenzenes as Selective Inhibitors of Platelet Activation at the PAR1 Receptor.

Dockendorff C, Aisiku O, Verplank L, Dilks JR, Smith DA, Gunnink SF, Dowal L, Negri J, Palmer M, Macpherson L, Schreiber SL, Flaumenhaft R. Dockendorff C, et al. ACS Med Chem Lett. 2012 Mar 8;3(3):232-237. doi: 10.1021/ml2002696. Epub 2012 Jan 30. ACS Med Chem Lett. 2012. PMID: 22408714 Free PMC article.

3

Route exploration and synthesis of the reported pyridone-based PDI inhibitor STK076545.

Greve E, Lindeman SV, Scartelli C, Lin L, Flaumenhaft R, Dockendorff C. Greve E, et al. Org Biomol Chem. 2020 Sep 14;18(34):6665-6681. doi: 10.1039/d0ob01205j. Epub 2020 Aug 19. Org Biomol Chem. 2020. PMID: 32812971 Free PMC article.

4

Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19.

Schmaier AA, Pajares Hurtado GM, Manickas-Hill ZJ, Sack KD, Chen SM, Bhambhani V, Quadir J, Nath AK, Collier AY, Ngo D, Barouch DH, Shapiro NI, Gerszten RE, Yu XG; MGH COVID-19 Collection and Processing Team; Peters KG, Flaumenhaft R, Parikh SM. Schmaier AA, et al. JCI Insight. 2021 Oct 22;6(20):e151527. doi: 10.1172/jci.insight.151527. JCI Insight. 2021. PMID: 34506304 Free PMC article.

5

Growth factor control of extracellular proteolysis.

Rifkin DB, Moscatelli D, Bizik J, Quarto N, Blei F, Dennis P, Flaumenhaft R, Mignatti P. Rifkin DB, et al. Cell Differ Dev. 1990 Dec 2;32(3):313-8. doi: 10.1016/0922-3371(90)90045-x. Cell Differ Dev. 1990. PMID: 1711916 Review.

6

Activation of latent transforming growth factor beta.

Flaumenhaft R, Kojima S, Abe M, Rifkin DB. Flaumenhaft R, et al. Adv Pharmacol. 1993;24:51-76. doi: 10.1016/s1054-3589(08)60933-3. Adv Pharmacol. 1993. PMID: 8504067 Review. No abstract available.

7

Interaction of basic fibroblast growth factor with extracellular matrix and receptors.

Moscatelli D, Flaumenhaft R, Saksela O. Moscatelli D, et al. Ann N Y Acad Sci. 1991;638:177-81. doi: 10.1111/j.1749-6632.1991.tb49028.x. Ann N Y Acad Sci. 1991. PMID: 1664684 No abstract available.

8

Mechanisms controlling the extracellular activity of basic fibroblast growth factor and transforming growth factor.

Rifkin DB, Moscatelli D, Flaumenhaft R, Sato Y, Saksela O, Tsuboi R. Rifkin DB, et al. Ann N Y Acad Sci. 1991;614:250-8. doi: 10.1111/j.1749-6632.1991.tb43707.x. Ann N Y Acad Sci. 1991. PMID: 2024887 Review. No abstract available.

9

Role of the latent TGF-beta binding protein in the activation of latent TGF-beta by co-cultures of endothelial and smooth muscle cells.

Flaumenhaft R, Abe M, Sato Y, Miyazono K, Harpel J, Heldin CH, Rifkin DB. Flaumenhaft R, et al. J Cell Biol. 1993 Feb;120(4):995-1002. doi: 10.1083/jcb.120.4.995. J Cell Biol. 1993. PMID: 8432736 Free PMC article.

10

The extracellular regulation of growth factor action.

Flaumenhaft R, Rifkin DB. Flaumenhaft R, et al. Mol Biol Cell. 1992 Oct;3(10):1057-65. doi: 10.1091/mbc.3.10.1057. Mol Biol Cell. 1992. PMID: 1421565 Free PMC article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

139 results

Search Page